Dacarbazine, a chemotherapeutic against metastatic melanoma and a reference drug for new treatment modalities

Journal Title: Advances in Hygiene and Experimental Medicine - Year 2011, Vol 65, Issue 0

Abstract

Melanoma is a tumour derived from melanocytes, cells of neuroectodermal origin. Melanoma treatment represents a challenge to oncologists due to its aggressive course and early and multiple metastases. Surgical excision of lesions is a highly effective intervention, but only in early stages. In contrast, median survival of patients with metastatic melanoma is still below one year. In 2011 the FDA and EMA have approved new drugs, ipilimumab and vemurafenib, that might be a major breakthrough in treating patients with advanced melanoma. However, time is needed to conclude whether they replace dacarbazine, a drug used for over 30 years in the therapy of metastatic melanoma, even if the response rate was only 10–15%. The mechanism of dacarbazine action is not clear but it is probably based on methylation of purine bases in DNA. The low therapeutic efficacy of dacarbazine might be the consequence of rapid removal of DNA lesions by repair systems. A high melanoma chemoresistance is also driven by the extent and nature of alterations in signal transductions in tumour cells. None of the previously conducted trials proved superiority of any treatment modality over monotherapy with dacarbazine. Higher response rates did not correlate with survival benefit, and more intense adverse effects were frequently observed. There are some expectations for targeted therapy and immunotherapy, which have already demonstrated some efficacy in clinical studies. This review aims at providing the current knowledge on dacarbazine and its analogue, temozolomide, including the latest results of clinical studies combining these drugs with other treatment protocols.

Authors and Affiliations

Kamila Koprowska, Małgorzata Czyż

Keywords

Related Articles

The role of genetic and environmental factors in the etiology of esophageal atresia and tracheo-esophageal fistula

Esophageal atresia and tracheo-esophageal fistula are severe congenital malformations, whose etiology is still poorly understood. So far, numerous genetic and environmental factors that may contribute to the occurrence o...

Immunology of the eye

The eye is an organ of sight characterized by unusual immunological properties, resulting from its anatomical structure and physiology, as well as the presence of specific elements that, through the mechanisms of innate...

A novel way to induce coronary hyperaemia

Coronary angiography and measurement of fractional flow reserve (FFR) are used for anatomical and functional assessment of coronary stenoses. The achievement of maximal coronary hyperaemia is crucial for an accurate calc...

Link between rheumatoid arthritis and chronic periodontitis

Chronic periodontitis is an infectious disease associated with the progressive destruction of periodontal tissues. In recent years, more and more data indicate an existing relationship between periodontal disease and rhe...

Download PDF file
  • EP ID EP66568
  • DOI -
  • Views 172
  • Downloads 0

How To Cite

Kamila Koprowska, Małgorzata Czyż (2011). Dacarbazine, a chemotherapeutic against metastatic melanoma and a reference drug for new treatment modalities. Advances in Hygiene and Experimental Medicine, 65(0), 734-751. https://europub.co.uk/articles/-A-66568